Viehbacher Christopher 4

4 · BIOGEN INC. · Filed Dec 5, 2022

Form 4

Period: 2022-12-01

DirectorPresident and CEO

Transactions

Award
Performance Stock Unit
2022-12-01+45,998→ 45,998 total
→ Common Stock (45,998 underlying)
Award
Stock Option
2022-12-01+80,522→ 80,522 total
Exercise: $301.85Exp: 2032-12-01→ Common Stock (80,522 underlying)
Award
Restricted Stock Unit
2022-12-01+7,040→ 7,040 total
→ Common Stock (7,040 underlying)

Footnotes (4)

[F1]The Stock Options are eligible to vest and become exercisable in approximately equal annual installments on the first, second and third anniversaries of the grant date of December 1, 2022.
[F2]Each Performance Stock Unit ("PSU") or Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock.
[F3]Each RSU is eligible to vest on the third anniversary of the grant date of December 1, 2022.
[F4]This represents the reporting person's PSUs that will be eligible for vesting based on achievement of absolute stock price compound annual growth rate goals ("Absolute CAGR PSUs") over a three-year performance period ending on November 30, 2025. The number of Absolute CAGR PSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.

Documents

1 file